Press monitoring
The evolution of DNA databases—Recommendations for new European STR loci
10.4.2006 | Press monitoring
Following a recent meeting by the ENFSI and EDNAP groups on the 4–5 April, 2005, in Glasgow, UK, it was unanimously agreed that the process of standardization within Europe should take account of recent work that unequivocally demonstrated that chance of obtaining a result from a degraded sample was increased when small amplicons (mini-STRs) were...
Schwarz Pharma reveals positive data on neuropathic pain drug Lacosamide
9.4.2006 | Press monitoring
MONHEIM, Germany (AFX) - Schwarz Pharma AG said that phase III data on its Lacosamide drug showed clinically relevant and statistically significant reduction in diabetic neuropathic pain, paving the way for filing for approval with European an US regulatory authorities.
First Demonstration of Therapeutic Gene Silencing in Primates with Systemic RNAi
9.4.2006 | Press monitoring
Alnylam Pharmaceuticals, Inc. announced the first published demonstration in primates that a systemically delivered RNAi therapeutic can potently silence an endogenous disease-causing gene in a clinically relevant manner.
Australian local farmer groups want GM ignorance to end
9.4.2006 | Press monitoring
Western Australian graingrowers want to know more about genetically modified (GM) crops so that they can make informed decisions about adopting them into their farming systems.
Tool to study brain development leads to new drugs
8.4.2006 | Press monitoring
Scientists have made available a powerful new tool for studying brain development, which will help scientists discover the genetic origins of brain cancers, which could speed development of novel drugs to treat them. The tool, called the mouse Brain Gene Expression Map (BGEM), will identify brain disorders, such as tumours and some psychiatric...
Pharmaxis' First Product, Aridol, Approved by Therapeutic Goods Administration
8.4.2006 | Press monitoring
Specialist pharmaceutical company Pharmaxis Ltd announced today that the Therapeutic Goods Administration (TGA) has approved its first product, Aridol(TM), for commercial sale in Australia. This represents a rare example of an Australian human therapeutic product developed in Australia from concept to commercialisation.
Adult cells in mice shown to mimic embryonic stem cells
8.4.2006 | Press monitoring
German scientists said on Friday they had isolated sperm-producing stem cells that have similar properties to embryonic stem cells from adult mice.
Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors
7.4.2006 | Press monitoring
By far, adenovirus (AdV)-mediated gene therapy is one of the most promising approaches, as has confirmed by studies relating to animal tumor models and clinical trials. Dendritic cells (DCs) are highly efficient, specialized antigen-presenting cells, and DC-based tumor vaccines are regarded as having much potential in cancer immu...
First Clinical Trial of Gene Therapy for Muscular Dystrophy Now Under Way
7.4.2006 | Press monitoring
The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina at Chapel Hill's School of Medicine and the University of Pittsburgh. In the trial, six boys with DMD will receive replacement genes for an essential muscle...
Cloned horses latest move for controversial field
7.4.2006 | Press monitoring
The company that cloned the first horse to be sold commercially said on Thursday it plans to market 22 similar animals before 2008, marking another step forward for the controversial technology.
